Elevance Health Inc. (ELV) FCF/Share TTM
The fcf/share ttm for Elevance Health Inc. (ELV) is $29.26 with a period-over-period change of +104.50%. Free cash flow per share divides trailing free cash flow by shares outstanding, showing cash generation per share.
ELV FCF/Share TTM Chart
FCF/Share TTM History
| Date | FCF/Share TTM | % Change |
|---|---|---|
| Q1 2026 | $29.26 | +104.50% |
| Q4 2025 | $14.31 | (14.22%) |
| Q3 2025 | $16.68 | (29.42%) |
| Q2 2025 | $23.64 | +46.16% |
| Q1 2025 | $16.17 | (17.90%) |
| Q4 2024 | $19.70 | +427.14% |
| Q3 2024 | $3.74 | +6.36% |
| Q2 2024 | $3.51 | (64.16%) |
| Q1 2024 | $9.80 | (65.83%) |
| Q4 2023 | $28.69 | (17.72%) |
| Q3 2023 | $34.87 | (21.57%) |
| Q2 2023 | $44.45 | (4.25%) |
| Q1 2023 | $46.42 | +54.51% |
| Q4 2022 | $30.05 | (29.99%) |
| Q3 2022 | $42.92 | +30.22% |
| Q2 2022 | $32.96 | +10.90% |
| Q1 2022 | $29.72 | +0.26% |
| Q4 2021 | $29.64 | (23.08%) |
| Q3 2021 | $38.54 | +65.00% |
| Q2 2021 | $23.35 | (39.97%) |
| Q1 2021 | $38.91 | +1.06% |
| Q4 2020 | $38.50 | +37.68% |
| Q3 2020 | $27.96 | (28.30%) |
| Q2 2020 | $39.00 | +69.50% |
| Q1 2020 | $23.01 | +19.10% |
| Q4 2019 | $19.32 | +21.00% |
| Q3 2019 | $15.97 | +38.60% |
| Q2 2019 | $11.52 | +49.70% |
| Q1 2019 | $7.69 | (22.94%) |
| Q4 2018 | $9.98 | +195.26% |
| Q3 2018 | $3.38 | (68.42%) |
| Q2 2018 | $10.71 | (0.49%) |
| Q1 2018 | $10.76 | (16.46%) |
| Q4 2017 | $12.88 | (32.26%) |
| Q3 2017 | $19.01 | +39.55% |
| Q2 2017 | $13.62 | (7.77%) |
| Q1 2017 | $14.77 | +51.45% |
| Q4 2016 | $9.75 | (19.12%) |
| Q3 2016 | $12.06 | +24.45% |
| Q2 2016 | $9.69 | (16.46%) |
| Q1 2016 | $11.60 | (10.61%) |
| Q4 2015 | $12.98 | +26.59% |
| Q3 2015 | $10.25 | (8.14%) |
| Q2 2015 | $11.16 | +5.55% |
| Q1 2015 | $10.57 | +11.67% |
| Q4 2014 | $9.47 | (4.72%) |
| Q3 2014 | $9.94 | (17.88%) |
| Q2 2014 | $12.10 | +26.07% |
| Q1 2014 | $9.60 | +16.73% |
| Q4 2013 | $8.22 | (15.46%) |
| Q3 2013 | $9.73 | +62.58% |
| Q2 2013 | $5.98 | (6.15%) |
| Q1 2013 | $6.37 | (11.36%) |
| Q4 2012 | $7.19 | +56.14% |
| Q3 2012 | $4.61 | (43.37%) |
| Q2 2012 | $8.13 | (6.27%) |
| Q1 2012 | $8.68 | +3.02% |
| Q4 2011 | $8.42 | (12.06%) |
| Q3 2011 | $9.58 | +21.21% |
| Q2 2011 | $7.90 | +23.76% |
| Q1 2011 | $6.38 | +150.84% |
| Q4 2010 | $2.54 | +143.88% |
| Q3 2010 | $1.04 | (52.01%) |
| Q2 2010 | $2.17 | (11.25%) |
| Q1 2010 | $2.45 | (58.87%) |
| Q4 2009 | $5.96 | (9.09%) |
| Q3 2009 | $6.55 | +24.43% |
| Q2 2009 | $5.27 | +11.27% |
| Q1 2009 | $4.73 | +7.69% |
| Q4 2008 | $4.40 | (15.83%) |
| Q3 2008 | $5.22 | +12.53% |
| Q2 2008 | $4.64 | (16.77%) |
| Q1 2008 | $5.58 | (23.83%) |
| Q4 2007 | $7.32 | (0.61%) |
| Q3 2007 | $7.36 | +0.99% |
| Q2 2007 | $7.29 | +12.92% |
| Q1 2007 | $6.46 | +4.24% |
| Q4 2006 | $6.20 | +14.40% |
| Q3 2006 | $5.42 | (7.08%) |
| Q2 2006 | $5.83 | (6.46%) |
| Q1 2006 | $6.23 | +35.15% |
| Q4 2005 | $4.61 | +5.55% |
| Q3 2005 | $4.37 | +22.01% |
| Q2 2005 | $3.58 | +43.50% |
| Q1 2005 | $2.49 | +30.99% |
| Q4 2004 | $1.90 | (45.06%) |
| Q3 2004 | $3.47 | +8.81% |
| Q2 2004 | $3.19 | (18.60%) |
| Q1 2004 | $3.91 | +7.70% |
| Q4 2003 | $3.63 | +6.87% |
| Q3 2003 | $3.40 | (4.27%) |
| Q2 2003 | $3.55 | +5.98% |
| Q1 2003 | $3.35 | - |
About Elevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Gail Koziara Boudreaux